SKYCovion COVID-19 Vaccine Authorized By MHRA
Portfolio Pulse from Bill Haddad
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has authorized SKYCovion's COVID-19 vaccine for emergency use.
May 26, 2023 | 5:28 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
GSK is mentioned in the article, but it is unclear if they are directly involved with the SKYCovion COVID-19 vaccine.
The article mentions GSK, but it does not provide any information about their involvement with the SKYCovion COVID-19 vaccine. As a result, it is difficult to determine the potential impact on GSK's stock price in the short term.
CONFIDENCE 75
IMPORTANCE 50
RELEVANCE 50